A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Feihong Luo
Children's Hospital of Fudan University
Principal Investigator - Guimei Li
Shandong Provincial Hospital
Principal Investigator - Jin Wu
West China Second University Hospital
Principal Investigator - Pin Li
Shanghai Children's Hospital
Principal Investigator - Wei Gu
Children's Hospital of Nanjing Medical University
Principal Investigator - Xiaobo Chen
Children's Hospital of The Capital Institute of Pediatrics
Principal Investigator - Xiaoping Luo
Tongji Hospital
Principal Investigator - Xinran Cheng
Chengdu Women's and Children's Central Hospital
Principal Investigator - Ying Xin
Shengjing Hospital of China Medical Hospital
Principal Investigator - Yu Yang
Jiangxi Province Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Sept 2022
- Primary completion
- 28 Feb 2025
- Completion
- 28 Feb 2025
- Last update posted
- 28 Feb 2023
- Registered enrollment
- 38
- Registry id
- NCT05353192
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.